Patents by Inventor Chad James Pickens

Chad James Pickens has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Ready to Use Ketorolac Formulations
    Publication number: 20220023260
    Abstract: Disclosed in certain embodiments is a pharmaceutical composition for parenteral administration comprising: an aqueous solution comprising ketorolac or a pharmaceutically acceptable salt thereof in an amount from about 0.1 mg/mL to about 10 mg/mL; and a pharmaceutically acceptable excipient; wherein the formulation is substantially free of alcohol.
    Type: Application
    Filed: August 9, 2021
    Publication date: January 27, 2022
    Inventors: Joseph V. Pergolizzi, Alexander Mironov, Chad James Pickens, Douglas Giles Johnson
  • Ready to use ketorolac formulations
    Patent number: 11116750
    Abstract: Disclosed in certain embodiments is a pharmaceutical composition for parenteral administration comprising: an aqueous solution comprising ketorolac or a pharmaceutically acceptable salt thereof in an amount from about 0.1 mg/mL to about 10 mg/mL; and a pharmaceutically acceptable excipient; wherein the formulation is substantially free of alcohol.
    Type: Grant
    Filed: December 7, 2018
    Date of Patent: September 14, 2021
    Assignee: RTU Pharmaceuticals, LLC
    Inventors: Joseph V. Pergolizzi, Alexander Mironov, Chad James Pickens, Douglas Giles Johnson
  • Ready to use ketorolac formulations
    Patent number: 10278959
    Abstract: Disclosed in certain embodiments is a pharmaceutical composition for parenteral administration comprising: an aqueous solution comprising ketorolac or a pharmaceutically acceptable salt thereof in an amount from about 0.1 mg/mL to about 10 mg/mL; and a pharmaceutically acceptable excipient; wherein the formulation is substantially free of alcohol.
    Type: Grant
    Filed: April 6, 2018
    Date of Patent: May 7, 2019
    Assignee: RTU Pharmaceuticals, LLC
    Inventors: Joseph V. Pergolizzi, Alexander Mironov, Chad James Pickens, Douglas Giles Johnson
  • Ready to Use Ketorolac Formulations
    Publication number: 20190105301
    Abstract: Disclosed in certain embodiments is a pharmaceutical composition for parenteral administration comprising: an aqueous solution comprising ketorolac or a pharmaceutically acceptable salt thereof in an amount from about 0.1 mg/mL to about 10 mg/mL; and a pharmaceutically acceptable excipient; wherein the formulation is substantially free of alcohol.
    Type: Application
    Filed: December 7, 2018
    Publication date: April 11, 2019
    Inventors: Joseph V. Pergolizzi, Alexander Mironov, Chad James Pickens, Douglas Giles Johnson
  • Ready to Use Ketorolac Formulations
    Publication number: 20180280351
    Abstract: Disclosed in certain embodiments is a pharmaceutical composition for parenteral administration comprising: an aqueous solution comprising ketorolac or a pharmaceutically acceptable salt thereof in an amount from about 0.1 mg/mL to about 10 mg/mL; and a pharmaceutically acceptable excipient; wherein the formulation is substantially free of alcohol.
    Type: Application
    Filed: April 6, 2018
    Publication date: October 4, 2018
    Inventors: Joseph V. Pergolizzi, Alexander Mironov, Chad James Pickens, Douglas Giles Johnson
  • Ready to use ketorolac formulations
    Patent number: 9962371
    Abstract: Disclosed in certain embodiments is a pharmaceutical composition for parenteral administration comprising: an aqueous solution comprising ketorolac or a pharmaceutically acceptable salt thereof in an amount from about 0.1 mg/mL to about 10 mg/mL; and a pharmaceutically acceptable excipient; wherein the formulation is substantially free of alcohol.
    Type: Grant
    Filed: July 15, 2016
    Date of Patent: May 8, 2018
    Assignee: RTU PHARMACEUTICALS, LLC
    Inventors: Joseph V. Pergolizzi, Alexander Mironov, Chad James Pickens, Douglas Giles Johnson
  • Ready to Use Ketorolac Formulations
    Publication number: 20170007575
    Abstract: Disclosed in certain embodiments is a pharmaceutical composition for parenteral administration comprising: an aqueous solution comprising ketorolac or a pharmaceutically acceptable salt thereof in an amount from about 0.1 mg/mL to about 10 mg/mL; and a pharmaceutically acceptable excipient; wherein the formulation is substantially free of alcohol.
    Type: Application
    Filed: July 15, 2016
    Publication date: January 12, 2017
    Inventors: Joseph V. Pergolizzi, Alexander Mironov, Chad James Pickens, Douglas Giles Johnson
  • Ready to use ketorolac formulations
    Patent number: 9421191
    Abstract: Disclosed in certain embodiments is a pharmaceutical composition for parenteral administration comprising: an aqueous solution comprising ketorolac or a pharmaceutically acceptable salt thereof in an amount from about 0.1 mg/mL to about 10 mg/mL; and a pharmaceutically acceptable excipient; wherein the formulation is substantially free of alcohol.
    Type: Grant
    Filed: October 21, 2011
    Date of Patent: August 23, 2016
    Assignee: RTU PHARMACEUTICALS, LLC
    Inventors: Joseph V. Pergolizzi, Alexander Mironov, Chad James Pickens, Douglas Giles Johnson
  • Ready to Use Ketorolac Formulations
    Publication number: 20120101142
    Abstract: Disclosed in certain embodiments is a pharmaceutical composition for parenteral administration comprising: an aqueous solution comprising ketorolac or a pharmaceutically acceptable salt thereof in an amount from about 0.1 mg/mL to about 10 mg/mL; and a pharmaceutically acceptable excipient; wherein the formulation is substantially free of alcohol.
    Type: Application
    Filed: October 21, 2011
    Publication date: April 26, 2012
    Applicant: RTU PHARMACEUTICALS, LLC
    Inventors: Joseph V. Pergolizzi, Alexander Mironov, Chad James Pickens, Douglas Giles Johnson